Presage sets the stage for commercial expansion with $13M financing and new Phase 0 trial agreements with Merck and Maverick Therapeutics

Seattle, WA – March 2, 2021 – Presage Biosciences, a biotechnology company pioneering a new cancer drug development approach using its Comparative In Vivo Oncology (CIVO®) intratumoral microdosing platform, today announced a $13 million financing and new research collaborations with Merck (NYSE:MRK) and Maverick Therapeutics.

TrakCel fuels growth and increased market access through strategic investment round

Cardiff, UK, March 3, 2021 ‒ TrakCel, a leading supplier of cellular orchestration solutions supporting the cell and gene therapy industry, today announces that it has closed its latest funding round led by AmerisourceBergen and Labcorp (NYSE: LH). These strategic investments enable further transformation of TrakCel’s cellular therapy orchestration solution, growth of its existing partner ecosystem, and continued global expansion. 

Celiac Disease Foundation advocates urge congress To continue support of celiac disease research funding

LOS ANGELES – (February 18, 2021) – Celiac disease afflicts millions of Americans, most of whom are undiagnosed, and is second only to end-stage renal disease in perceived burden by patients and caregivers. Despite these appalling facts, the federal government has never been a major funder of celiac disease research. As a direct consequence, celiac disease is the most prevalent genetic autoimmune disease with no FDA-approved treatments.

Walgreens to make Pixel by Labcorp™ COVID-19 PCR Test Home Collection Kit available over-the-counter at stores nationwide

DEERFIELD, Ill. & BURLINGTON, N.C., February 24, 2021 - As part of Walgreens ongoing efforts to increase access to COVID-19 testing in communities across the U.S., the company announced today it has entered into an agreement with Labcorp™ to sell Pixel by Labcorp COVID-19 PCR Test Home Collection Kits over-the-counter in up to 6,000 Walgreens stores nationwide beginning in spring of this year. Walgreens is making significant strides to increase on-site testing capacity at more than 5,000 Walgreens pharmacy locations by April 1, with more than half of sites located in socially vulnerable areas.

Natick, Massachusetts Mass Vaccination Site | Opening Remarks | Bill Haas, senior vice president, Northeast Division, Labcorp

Thank you for joining us today at our mass vaccination site here at the Natick Mall. I’m Bill Haas, senior vice president of the northeast division at Labcorp. We’re thrilled to be working across the commonwealth to make it easier for people to get tested and vaccinated, as we all work together to slow the spread of COVID-19. 

Labcorp is scheduled to speak at Citi's 2021 Healthcare Services, Medtech, Tools, & HCIT virtual conference

BURLINGTON, N.C. --(BUSINESS WIRE)--Feb. 23, 2021-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of the executive management team will participate in a virtual fireside chat at Citi's 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference on Thursday, Feb. 25 at 1:30 p.m. ET.

Labcorp and EmblemHealth announce strategic collaboration to serve over 3 million members In New York communities

BURLINGTON, N.C., February 22, 2021— Labcorp (NYSE: LH), a leading global life sciences company, and EmblemHealth, one of the nation’s largest nonprofit health insurers, have entered into a strategic collaboration to provide laboratory testing services to the more than 3 million participants enrolled in EmblemHealth plans in New York and New Jersey. The preferred provider agreement allows EmblemHealth to offer its members best-in-class service and easier access to high-quality lab testing.